Gamma Delta Work Makes Cautious Inroads into Clinic

Gamma Delta Work Makes Cautious Inroads into Clinic

Jacob Plieth of Evaluate writes about TC Biopharm’s treatment of the first patient cohort in a study of OmnImmune (TCB002), which represents the fourth clinical trial involving gamma-delta cells in the West. The UK biotech venture reports that the trial is a...

Pin It on Pinterest